Avion Wealth’s Medline Inc MDLN Stock Holding History

Avion Wealth’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3K	Buy	90 +1	+1%	+$40	﹤0.01%	1012
2026 Q1	$3K	Buy	+89	New	+$3.93K	﹤0.01%	830

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Avion Wealth's MDLN Position: Q2 2026 in Review

Avion Wealth increased its Medline Inc (MDLN) stake by 1.1% in Q2 2026, buying an estimated $40 and bringing the position to 90 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Avion Wealth first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Avion Wealth held 90 shares of Medline Inc worth $3K as of Q2 2026.
Avion Wealth bought 1 Medline Inc share in Q2 2026, an estimated $40.
Medline Inc made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1012 holding.
Avion Wealth first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.